Advertisement

Topics

Waldenström Macroglobulinemia (WM) Market Spotlight 2017: 10-Year Disease Incidence Forecast, Licensing and Acquisition Deals & Drug-Specific Revenue Forecasts – ResearchAndMarkets.com

10:04 EST 15 Feb 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Waldenström Macroglobulinemia (WM)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Waldenström Macroglobulinemia market, comprising key pipeline and marketed drugs, clinical trials, patent information, a 10-year disease incidence forecast, and licensingContinue reading

Cet article Waldenström Macroglobulinemia (WM) Market Spotlight 2017: 10-Year Disease Incidence Forecast, Licensing and Acquisition Deals & Drug-Specific Revenue Forecasts – ResearchAndMarkets.com est apparu en premier sur Biotech 365.

Original Article: Waldenström Macroglobulinemia (WM) Market Spotlight 2017: 10-Year Disease Incidence Forecast, Licensing and Acquisition Deals & Drug-Specific Revenue Forecasts – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Waldenström Macroglobulinemia (WM) Market Spotlight 2017: 10-Year Disease Incidence Forecast, Licensing and Acquisition Deals & Drug-Specific Revenue Forecasts – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...